Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
0.8780
+0.0979 (12.55%)
At close: Aug 15, 2025, 4:00 PM
0.8800
+0.0020 (0.23%)
After-hours: Aug 15, 2025, 7:34 PM EDT
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $74.43 million as of August 15, 2025. Its market cap has decreased by -77.08% in one year.
Market Cap
74.43M
Enterprise Value
-111.11M
1-Year Change
-77.08%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has decreased from $346.92M to $74.43M, a decrease of -78.54%. That is a compound annual growth rate of -20.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 74.43M | -50.94% |
| Dec 31, 2024 | 151.72M | -41.98% |
| Dec 29, 2023 | 261.49M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -30.31% |
| Dec 31, 2020 | 987.90M | 288.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 618.36B |
| Johnson & Johnson | 423.87B |
| AbbVie | 361.63B |
| UnitedHealth Group | 272.94B |
| AstraZeneca | 243.29B |
| Novartis AG | 236.22B |
| Abbott Laboratories | 229.50B |
| Novo Nordisk | 225.09B |